Research output per year
Research output per year
Personal profile
Research Interests
Pharmacoeconomics
Pharmacoepidemiology
Health economics
Tobacco control
Education/Academic qualification
PhD, Health Policy and Management, University of California, Berkeley
Fingerprint
Dive into the research topics where Yi-Wen Tsai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Superior benefits of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors for diabetic kidney disease: A cohort study
Chen, H.-L., Wang, I.-T., Tsai, Y.-W., Lee, Y.-H., Chen, C.-H., Chiang, C.-E. & Cheng, H.-M., 1 Jan 2025, In: Diabetes, Obesity and Metabolism. 27, 1, p. 174-183 10 p.Research output: Contribution to journal › Article › peer-review
-
Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan
Chen, K. A., Huang, W. M., Chen, E. Y. T., Ho, P. K., Chueh, C. H., Wen, Y. W., Chen, M. H., Chiang, N. J. & Tsai, Y. W., Dec 2024, In: BMC Cancer. 24, 1, 622.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pharmaceutical procurement profits and universal health coverage: Reform to a sustainable healthcare and financing system
Huang, W.-F., Fu, J.K.-C., Chueh, C.-H., Chen, H.-H., Shen, L.-J. & Tsai, Y.-W., 1 Nov 2024, In: Journal of the Formosan Medical Association. 123, 3, p. S242-S250 9 p.Research output: Contribution to journal › Article › peer-review
-
The 2017 Women’s Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study
Chueh, C. H., Ho, P. K., Li, W. H., Shiu, M. N., Wang, I. T., Wen, Y. W. & Tsai, Y. W., Dec 2024, In: BMC Public Health. 24, 1, 1674.Research output: Contribution to journal › Article › peer-review
Open Access -
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy
Chueh, C. H., Tsai, Y.-W., Chen, Z. R., Shiu, M. N., Wen, Y. W. & Chiang, N. J., Mar 2023, In: PharmacoEconomics. p. 307-319Research output: Contribution to journal › Article › peer-review
2 Scopus citations